The metabolic syndrome, a cluster of metabolic disorders often associated with visceral
obesity, increases cardiovascular mortality and morbidity. As the body's largest endocrine …

Adiponectin is an important adipocytokine secreted chiefly by fat containing adipocytes, and
plays a crucial role in glucose and lipid metabolism, inflammation and oxidative stress …

Visceral fat accumulation has a marked impact on atherosclerotic cardiovascular diseases
and metabolic syndrome clustering diabetes, dyslipidemia, and hypertension. Adiponectin …

Recent studies emphasize the role played by adiponectin in the homeostasis of adipose
tissue and in the pathogenesis of the metabolic syndrome, type 2 diabetes, and …

Adiponectin is the most abundant adipose-specific protein. Its expression is reduced in
obesity, insulin resistance and type 2 diabetes, and plasma concentrations are inversely …

Recent studies revealed that adipose tissue is not only an energy storing organ, but is a kind
of endocrine organ which secretes a variety of bioactive substances, so-called adipokines or …

Adiponectin is a recently described adipokine that has been recognized as a key regulator
of insulin sensitivity and tissue inflammation. It is produced by adipose tissue (white and …

Adiponectin is a white and brown adipose tissue hormone, also known as gelatin-binding
protein-28 (GBP28), AdipoQ, adipocyte complement-related protein (ACRP30), or apM1 …

Adiponectin is an adipocyte hormone that links visceral adiposity with insulin resistance and
atherosclerosis. It is unique among adipocyte-derived hormones in that its circulating …

Adiponectin is an adipocyte‐derived hormone that was discovered in 1995. Unlike leptin,
which was identified around the same time, the clinical relevance of adiponectin remained …